Other languages Syngene International Limited Bombay S.E.

Equities

SYNGENE

INE398R01022

Market Closed - Bombay S.E. Other stock markets 03:30:50 03/05/2024 pm IST			5-day change	1st Jan Change
678.7 ^INR	-1.27%		-2.80%	-3.20%

28/04	Syngene International Limited Submits an Appeal to the National Faceless Appeal Centre, for Assessment Year 2022-23	CI
26/04	Jefferies Downgrades Syngene International to Underperform From Hold, Adjusts Price Target to INR620 From INR690	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Syngene International Limited Recommends Final Dividend for the Financial Year 2024	24/04
Syngene International Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	24/04
Syngene International Limited Reports Earnings Results for the Full Year Ended March 31, 2024	24/04
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes	12/04
Syngene Biologics Manufacturing Facility to Be Operational for U.S. and European Customers from Mid-Year	15/03
Bristol Myers CEO says India to have largest R&D presence outside US by 2025	27/02
Syngene International Posts Gains in Fiscal Q3 Consolidated Net Profit	26/01
Syngene International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	25/01
Syngene International Limited Appoints Mr. Sibaji Biswas as Additional Director Designated as Executive Director, Effective on April 01, 2024	25/01
Syngene International Completes Acquisition of Stelis Biopharma's Biologics Plant	04/12
Syngene International Limited completed the acquisition of Unit 3 biologics manufacturing facility in Bangalore from Stelis Biopharma Private Limited for INR 6.2 billion.	01/12
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China	27/11
Syngene International COO Steps Down	31/23/31
Syngene International Limited Announces Resignation of Mahesh Bhalgat as Chief Operating Officer, Effective January 31, 2024	31/23/31
Syngene International Limited Announces Resignation of Carl Decicco as Non-Executive Director	25/23/25
Syngene International's Consolidated Profit Jumps in Fiscal Q2; Shares Slump 7%	18/23/18
Syngene International Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	17/23/17
Syngene International Limited Announces Retirement of Joydeep Kant as Sr. Vice President - Development Services, Effective October 31, 2023	08/23/08
Syngene International Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023	28/23/28
Syngene International Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	26/23/26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Syngene International Limited Bombay S.E.

Equities

SYNGENE

INE398R01022

Other languages

Filters